Case Control Study
Copyright ©The Author(s) 2017.
World J Hepatol. Sep 18, 2017; 9(26): 1101-1107
Published online Sep 18, 2017. doi: 10.4254/wjh.v9.i26.1101
Table 1 General characteristics of the study
CharacteristicsAncestral South Indians
North-East Indians
ControlsPatientsP value1ControlsPatientsP value1
(n = 138) (mean ± SD)(n = 93) (mean ± SD)(n = 109) (mean ± SD)(n = 163) (mean ± SD)
Age (yr)34.2 ± 11.935.3 ± 8.00.4338.5 ± 12.736.5 ± 9.20.13
Gender male/female (n)95/4387/60.6472/37150/130.84
Waist circumference (cm)83.3 ± 9.494.7 ± 10.20.0181.1 ± 10.793.8 ± 10.10.01
Hip circumference (cm)93.0 ± 7.1100.5 ± 8.60.0191.2 ± 6.995.1 ± 8.50.01
Waist/hip ratio0.89 ± 0.060.95 ± 0.130.010.89 ± 0.070.99 ± 0.120.01
BMI (kg/m2)23.2 ± 4.027.7 ± 4.10.0122.1 ± 3.525.7 ± 4.00.01
ALT (IU/L)19.8 ± 7.688.1 ± 49.50.0124.6 ± 7.9119.3 ± 68.30.01
AST (IU/L)21.2 ± 5.455.3 ± 25.60.0124.6 ± 6.972.3 ± 39.80.01
Triglycerides (mg/dL)134.8 ± 72.6169.7 ± 82.10.01131.4 ± 60.8180.3 ± 93.70.05
HDL (mg/dL)38.7 ± 8.536.3 ± 6.90.0947.9 ± 28.740.5 ± 13.80.02
Table 2 Genotype distribution of Tm6SF2 and PNPLA3 variants in the two ethnicities studies
Ancestral South IndiansNorth-East Indians
TM6SF2 rs58542926
TM6SF2 rs58542926
Controls (n)Patients (n)Odds95%CIχ2P value1Controls (n)Patients (n)Odds95%CIχ2P value1
Wild (CC)110612.71.37-5.315.280.0004801101.510.86-2.662.290.31
Heterozygous (CT)18222244
Homozygous (TT)0726
PNPLA3 rs2281135
Wild (GG)79491.340.78-2.332.120.3463711.91.5-3.146.480.03
Heterozygous (GA)45353271
Homozygous (AA)46917
Table 3 Association of variants with clinical data
Ancestral South Indians
North-East Indians
CCCTTTGGGAAAχ2P value1CCCTTTGGGAAAχ2P value1
TM6SF2 rs58542926
BMI
< 22.9491220.030.98751858.240.01
> 22.911028494472
PNPLA3 rs2281135
BMI
< 22.9382320.590.744837100.0770.96
> 22.982528715814
TM6SF2 rs58542926
ALT
< 30891716.520.038652012.450.29
> 3056195108427
PNPLA3 rs2281135
ALT
< 30643941.30.525428410.270.005
> 3042335667119
TM6SF2 rs58542926
AST
< 309018010.190.006682030.960.61
> 3055186105425
PNPLA3 rs2281135
AST
< 30654032.890.23543075.550.06
> 3041326666916
TM6SF2 rs58542926
TG
< 150541341.640.43582563.890.14
> 1503312160291
PNPLA3 rs2281135
TG
< 150422580.290.86493282.490.28
> 15029143394011
TM6SF2 rs58542926
HDL
> 4026502.030.36492230.050.97
< 405718359273
PNPLA3 rs2281135
HDL
> 40201102.520.28392870.50.77
< 4046266715814
Table 4 Comparison of clinical data within the ethnicities
CharacteristicsControls
Patients
ASI controls (n = 138) (mean ± SD)NEI controls (n = 109) (mean ± SD)P value1ASI patients (n = 93) (mean ± SD)NEI patients (n = 163) (mean ± SD)P value
Age (yr)34.2 ± 11.938.5 ± 12.70.00635.3 ± 8.036.5 ± 9.20.29
Gender male/female (n)95/4372/37-87/6150/13-
Waist circumference (cm)83.3 ± 9.481.1 ± 10.70.2794.7 ± 10.293.8 ± 10.10.54
Hip circumference (cm)93.0 ± 7.191.2 ± 6.90.23100.5 ± 8.695.1 ± 8.50.01
Waist/hip ratio0.89 ± 0.060.89 ± 0.071.00.95 ± 0.130.99 ± 0.120.03
BMI (kg/m2)23.2 ± 4.022.1 ± 3.50.0227.7 ± 4.125.7 ± 4.00.003
ALT (IU/L)19.8 ± 7.624.6 ± 7.90.0188.1 ± 49.5119.3 ± 68.30.01
AST (IU/L)21.2 ± 5.424.6 ± 6.90.0155.3 ± 25.672.3 ± 39.80.01
Triglycerides (mg/dL)134.8 ± 72.6131.4 ± 60.80.79169.7 ± 82.1180.3 ± 93.70.44
HDL (mg/dL)38.7 ± 8.547.9 ± 28.70.0236.3 ± 6.940.5 ± 13.80.01